Free Trial

Calliditas Therapeutics AB (publ) (CALT) SEC Filings & 10K Form

$22.00
-0.19 (-0.86%)
(As of 05/20/2024 ET)

Recent Calliditas Therapeutics AB (publ) SEC Filings

DateFilerForm TypeView
01/08/2024
7:28 AM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
4:13 PM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2023
3:05 PM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2023
3:05 PM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2023
3:05 PM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2023
3:05 PM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
3:21 PM
Calliditas Therapeutics AB (publ) (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CALT) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners